Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer.
Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer. Gynecol Oncol. 2008 Dec; 111(3):461-6.
View in:
PubMed
subject areas
Adult
Adult
Aged
Aged
Antibodies, Monoclonal
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Bevacizumab
CA-125 Antigen
CA-125 Antigen
Carboplatin
Carboplatin
Cisplatin
Cisplatin
Deoxycytidine
Deoxycytidine
Disease-Free Survival
Disease-Free Survival
Female
Female
Humans
Humans
Middle Aged
Middle Aged
Neoplasm Recurrence, Local
Neoplasm Recurrence, Local
Ovarian Neoplasms
Ovarian Neoplasms
Retrospective Studies
Retrospective Studies
authors with profiles
Debra L Richardson